Evidence map›Paper›PMID 23685206›Full record

ArticleBrain research bulletin2013

D-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling.

Jessica A Burket, Andrew D Benson, Amy H Tang, Stephen I Deutsch

Abstract read
In one paragraph

Article in Brain research bulletin, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Hypothesis-driven investigations of diverse pharmacological targets in two mouse models of autism.Autism research : official journal of the International Society for Autism Research · 2019
    Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jessica A BurketDepartment of Psychiatry and Behavioral Sciences, Eastern Virginia Medical School, Norfolk, VA 23507, USA.
Andrew D Benson
Amy H Tang
Stephen I Deutsch
Eastern Virginia Medical School · US

Funding

SIAH2-Dependent Proteolysis in Cell Migration, Tumor Growth and Cancer MetastasisR01CA140550 · NCI · EASTERN VIRGINIA MEDICAL SCHOOL · PI TANG, AMY H. · 2010 to 2014
$1.4M
Regulated Proteolysis in RAS Signal TransductionR01GM069922 · NIGMS · MAYO CLINIC ROCHESTER · PI TANG, AMY H. · 2004 to 2009
$1.3M
NCI NIH HHS R01 CA140550NIGMS NIH HHS R01 GM069922
6 · The paper itself

Abstract

The genetically inbred BTBR T+ Itpr3tf/J (BTBR) mouse is a proposed model of autism spectrum disorders (ASDs). Similar to several syndromic forms of ASDs, mTOR activity may be enhanced in this mouse strain as a result of increased Ras signaling. Recently, D-cycloserine, a partial glycineB site agonist that targets the NMDA receptor, was shown to improve the sociability of the Balb/c mouse strain, another proposed genetically inbred model of ASDs. NMDA receptor activation is an important regulator of mTOR signaling activity. Given the ability of D-cycloserine to improve the sociability of the Balb/c mouse strain and the regulatory role of the NMDA receptor in mTOR signaling, we wondered if D-cycloserine would improve the impaired sociability of the BTBR mouse strain. D-Cycloserine (320 mg/kg, ip) improved measures of sociability in a standard sociability paradigm and spontaneous grooming that emerged during social interaction with an ICR stimulus mouse in the BTBR strain; however, similar effects were observed in the Swiss Webster comparator strain, raising questions about their strain-selectivity. Importantly, the profile of D-cycloserine's effects on both measures of sociability and stereotypies is consistent with that of a desired medication for ASDs; specifically, a desired medication would not improve sociability at the expense of worsening stereotypic behaviors or vice versa.

Indexed as

Social BehaviorAnimalsBehavior, AnimalChild Development Disorders, PervasiveCycloserineDisease Models, AnimalGroomingMaleMAP Kinase Signaling SystemMiceMice, Inbred BALB CMice, Inbred StrainsMice, TransgenicStereotyped BehaviorTOR Serine-Threonine KinasesCycloserinemTOR protein, mouseTOR Serine-Threonine KinasesBTBR miced-CycloserineNMDA receptorSociabilityStereotypies

Identifiers

PMID23685206
PMCPMC5581963
OpenAlexW2143320745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.